HR 4408
115th Congress
House
Crime and Law Enforcement
Drug therapy
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Health personnel
Licensing and registrations
Prescription drugs
Opioid Addiction Prevention Act of 2017
Introduced: November 15, 2017
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 13, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Nov 17, 2017
Referred to the Subcommittee on Health.
Nov 15, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 15, 2017
Introduced in House
Plain-English summary
Opioid Addiction Prevention Act of 2017
This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law.
An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Committees of jurisdiction
4
Cosponsors
1